Almondz Global Securities Limited ALMONDZ NSEFINANCIAL
Almondz Global Securities Limited provides professional advisory and consultancy services in India. The company operates through Debt and Equity Market Operations, Corporate Finance/Advisory Fees, Wealth Advisory/Broking Activities, Finance Activities, Infrastructure Advisory, and Healthcare Services segments. It offers merchant banking, underwriting commission, corporate and loan syndication, and debts/bonds arrangement services, as well as deals/trades in shares and bonds. The company also provides broking and commission services for mutual funds, equity initial public offerings, capital gain bonds, government undertaking fixed deposits, and RBI taxable bonds, as well as stock and share broking services and other related ancillary services. In addition, it grant loans; and advisory services in relation to infrastructure projects. Further, the company operates an eye-care hospitals. Additionally, it provides private equity, M and A, infrastructure advisory, equity broking, wealth management, and debt portfolio management services and distribution; and technical and consultancy services in the areas of management, engineering, industrial, technical, and financial for infrastructure sectors. The company also operates commodity trading platforms for retail and corporate investors; engages in the real estate and healhcare activities, as well as provision of diagnostic and treatment services for various eye disorders. The company was incorporated in 1994 and is based in New Delhi, India. Almondz Global Securities Limited operates as a subsidiary of Avonmore Capital & Management Services Limited.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Compounding revenue at 36.5% over 5 years.
- Profit CAGR of 20.7% over 5 years.
CONS
- Trading 46.3% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ALMONDZ Almondz Global Securities Limited NSEFINANCIAL | 13.63 | 8.36 | ₹236.68 Cr | - | 10.38% | 10.74% | 36.47% | 20.71% |
| 2 | HDFCBANK HDFC Bank Limited NIFTY50NSEAIFINANCIAL | 744.55 | 16.61 | ₹11.46 L Cr | 1.75% | - | 13.82% | 32.50% | 20.39% |
| 3 | ICICIBANK ICICI Bank Limited NIFTY50NSEAIFINANCIAL | 1,256.40 | 16.81 | ₹9.01 L Cr | 0.88% | - | 16.36% | 19.65% | 16.78% |
| 4 | SBIN State Bank of India NIFTY50NSEAIFINANCIALPSU | 964.40 | 10.58 | ₹8.90 L Cr | 1.80% | - | 15.48% | 12.19% | 14.39% |
| 5 | KOTAKBANK Kotak Mahindra Bank Limited NIFTY50NSEAIFINANCIAL | 384.20 | 19.80 | ₹3.82 L Cr | 0.13% | - | 11.39% | 14.58% | 8.92% |
| 6 | LICI Life Insurance Corporation of India NIFTY_MIDNSEFINANCIALPSU | 411.35 | 9.06 | ₹2.60 L Cr | 2.43% | - | 42.36% | 7.61% | 16.86% |
| 7 | SHRIRAMFIN Shriram Finance Limited NIFTY50NSEFINANCIAL | 947.15 | 17.79 | ₹2.23 L Cr | 1.46% | - | 16.38% | 15.48% | 18.59% |
| 8 | SBILIFE SBI Life Insurance Company Limited NIFTY50NSEFINANCIAL | 1,830.10 | 74.06 | ₹1.84 L Cr | 0.15% | - | 13.70% | 11.67% | 12.81% |
| 9 | ICICIAMC ICICI PRUDENTIAL AMC LTD NIFTY_MIDNSEFINANCIAL | 3,538.50 | 53.19 | ₹1.75 L Cr | 0.70% | 98.30% | 85.80% | 28.94% | 29.58% |
Quarterly Results
Figures in INR.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | - | 34.01 Cr | 53.83 Cr | 29.53 Cr | 33.41 Cr | 54.86 Cr | 72.19 Cr |
| Cost of Revenue | - | 23.77 Cr | 41.49 Cr | 21.59 Cr | 23.65 Cr | 32.89 Cr | 46.99 Cr |
| Gross Profit | - | 10.24 Cr | 12.34 Cr | 7.94 Cr | 9.76 Cr | 21.97 Cr | 25.20 Cr |
| Operating Expenses | - | 7.41 Cr | 8.31 Cr | 3.66 Cr | 6.02 Cr | 12.34 Cr | 23.67 Cr |
| Operating Income | - | 2.83 Cr | 4.03 Cr | 4.28 Cr | 3.74 Cr | 9.63 Cr | 1.53 Cr |
| EBITDA | - | 4.84 Cr | 9.43 Cr | 10.66 Cr | 6.93 Cr | 17.24 Cr | 8.27 Cr |
| Interest Expense | - | 74.00 L | 83.00 L | 1.20 Cr | 1.11 Cr | 1.04 Cr | 1.01 Cr |
| Pretax Income | - | 2.95 Cr | 7.54 Cr | 8.07 Cr | 4.42 Cr | 14.68 Cr | 5.88 Cr |
| Tax Provision | - | 52.00 L | 1.39 Cr | 1.17 Cr | 55.00 L | 1.91 Cr | 70.00 L |
| Net Income | - | 2.43 Cr | 6.15 Cr | 6.90 Cr | 3.64 Cr | 12.77 Cr | 4.85 Cr |
| Diluted EPS | 0.16 | 0.14 | 0.36 | 0.40 | 0.21 | 0.73 | 0.28 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 74.92 Cr | 111.92 Cr | 151.12 Cr | 190.43 Cr |
| Cost of Revenue | - | 25.22 Cr | 31.58 Cr | 112.80 Cr | 125.12 Cr |
| Gross Profit | - | 49.70 Cr | 80.33 Cr | 38.32 Cr | 65.31 Cr |
| Operating Expenses | - | 41.67 Cr | 69.18 Cr | 25.96 Cr | 45.69 Cr |
| Operating Income | - | 8.04 Cr | 11.15 Cr | 12.36 Cr | 19.62 Cr |
| EBITDA | - | 21.98 Cr | 41.91 Cr | 27.64 Cr | 43.10 Cr |
| Interest Expense | - | 2.11 Cr | 2.57 Cr | 3.09 Cr | 4.36 Cr |
| Pretax Income | - | 17.76 Cr | 35.88 Cr | 20.28 Cr | 33.05 Cr |
| Tax Provision | - | 1.98 Cr | 1.81 Cr | 2.95 Cr | 4.33 Cr |
| Net Income | - | 15.78 Cr | 34.07 Cr | 17.33 Cr | 27.75 Cr |
| Diluted EPS | - | 0.97 | 1.16 | 1.02 | 1.63 |
Compounded Sales Growth
| 5 Years: | 36.47% |
| 1 Year: | 6.70% |
Compounded Profit Growth
| 5 Years: | 20.71% |
| 1 Year: | -22.20% |
Stock Price Performance
| 1 Year: | -32.72% |
| 6 Months: | -19.92% |
| 3 Months: | -13.90% |
| 1 Month: | -19.82% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 271.04 Cr | 317.07 Cr | 351.18 Cr | 383.28 Cr |
| Current Assets | - | 142.57 Cr | 172.16 Cr | 197.52 Cr | 70.96 Cr |
| Cash & Equivalents | - | 15.69 Cr | 11.80 Cr | 22.05 Cr | 6.29 Cr |
| Inventory | - | 3.98 L | 2.51 L | 1.99 L | 0 |
| Receivables | - | 32.09 Cr | 60.30 Cr | 52.13 Cr | 54.13 Cr |
| Total Liabilities | - | 60.96 Cr | 97.09 Cr | 109.78 Cr | 89.97 Cr |
| Current Liabilities | - | 53.93 Cr | 84.66 Cr | 98.72 Cr | 22.93 Cr |
| Long Term Debt | - | 1.99 Cr | 1.99 Cr | 1.99 Cr | 45.40 Cr |
| Total Debt | - | 20.52 Cr | 23.42 Cr | 53.11 Cr | 49.34 Cr |
| Total Equity | - | 210.07 Cr | 219.97 Cr | 241.40 Cr | 269.22 Cr |
| Shares Outstanding | - | 15.53 Cr | 16.09 Cr | 17.23 Cr | 17.36 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -13.73 Cr | 35.06 Cr | -9.43 Cr | -4.09 Cr |
| Investing Cash Flow | - | 1.94 Cr | -33.19 Cr | -12.83 Cr | -33.40 Cr |
| Financing Cash Flow | - | 6.61 Cr | -5.77 Cr | 32.51 Cr | 21.73 Cr |
| Capital Expenditure | - | -2.04 Cr | -5.90 Cr | -5.02 Cr | -1.97 Cr |
| Free Cash Flow | - | -15.78 Cr | 29.16 Cr | -14.45 Cr | -6.06 Cr |
| Net Change in Cash | - | -5.18 Cr | -3.90 Cr | 10.25 Cr | -15.76 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 66.3% | 71.8% | 25.4% | 34.3% |
| Operating Margin % | - | 10.7% | 10.0% | 8.2% | 10.3% |
| Net Margin % | - | 21.1% | 30.4% | 11.5% | 14.6% |
| ROE % | - | 7.5% | 15.5% | 7.2% | 10.3% |
| ROCE % | - | 3.7% | 4.8% | 4.9% | 5.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ALMONDZ